Search Results
Sep 10, 2026, 08:00 ET Beyond the Prescription: New GLP-1 Program Seeks to Bring Nutrition Support to the Medication Protocol
dose changes or discontinuation"Getting a prescription should be the beginning of a patient's treatment, not the end," said Devon Allen, MD, a physician who works with Top Nutrition Coaching. "GLP-1 medications can be an important tool for weight management, but patients also
More news about: Receptive
Sep 10, 2026, 08:00 ET New Playbook Reveals Health Systems Are Saving Millions on EHR Training
returned annually to help health systems move from traditional training to continuous, embedded learning.ELKRIDGE, Md., Sept. 10, 2026 /PRNewswire/ --
More news about: uPerform
Sep 10, 2026, 08:00 ET OncoHost to Present New PROphetNSCLC® Data at WCLC 2026 Demonstrating Predictive Performance Beyond Baseline Sampling
assay"."Immunotherapy is today the cornerstone of treatment for NSCLC patients without an oncogenic driving abnormality", added Fred Hirsch, MD, PhD, FASCO, Professor of Medicine & Pathology, Medical Oncologist, Clinical Advisor at OncoHost and co-author of the study. "The PROphet blood-based
More news about: OncoHost
Sep 10, 2026, 07:30 ET TenNor Therapeutics Reports Positive Phase IIa POC Data for Rifaquizinone (TNP-2092), the First Non-Surgical Therapy Candidate for Periprosthetic Joint Infection
see patients in this trial achieve cure—sparing them from the grueling surgical journey they would otherwise face."Professor Javad Parvizi, MD, FRCS, Professor of Orthopedic Surgery, Acibadem University, Istanbul, past president of the American Association of Hip and Knee Surgeons, and Co-Chair,
More news about: TenNor Therapeutics (Suzhou) Limited
Sep 10, 2026, 07:00 ET BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026)
study of GLIX1, an oral TET2 activator, for the treatment of recurrent or progressive high-grade gliomaPresenter: Ditte Primdahl, MD, Assistant Professor of Neurology, Northwestern MedicineSession type: E-poster presentation (displayed electronically on a number of poster
More news about: BioLineRx Ltd.; Hemispherian AS
Sep 10, 2026, 06:23 ET Trust Industry Turns to Peer Collaboration and Education as Technology, AI and Fiduciary Pressures Reach a Critical Inflection Point
highlight the value of education, peer exchange and industry collaboration for trust organizationsGAITHERSBURG, Md., Sept. 10, 2026 /PRNewswire/ -- As trust organizations navigate rapid advances in technology, evolving client
More news about: GreenHill Investment Reporting
Sep 10, 2026, 06:13 ET AI-Assisted Imaging Tool for Breast Cancer Could Tailor Screening for Women According to Individual Risk
Shen, and Heacock, other study co-investigators were Jungkyu Park, PhD; Felicia Pasadyn, MA; Qi Lei, PhD; Alana Lewin, MD; Krzysztof Geras, PhD; Linda Moy, MD; and Freya Schnabel, MD.STUDY DOI10.2214/AJR.26.34951STUDY LINK
More news about: NYU Langone Health System
Sep 10, 2026, 01:47 ET Full-Life Technologies kondigt IND-goedkeuring van de Amerikaanse FDA en goedkeuring van de Australische regelgevende instanties aan voor klinische fase 1-studie naar [²²⁵Ac]Ac-FL-261
belangrijke mijlpaal voor FL-261 en onze strategie om gerichte alfatherapie uit te breiden naar verschillende solide tumoren", aldus Debora Barton, MD, Chief Medical Officer van Full-Life Technologies. "[225Ac]Ac-FL-261 is ontworpen om selectief te mikken op c-MET-expresserende tumoren
More news about: Full-Life Technologies
Sep 09, 2026, 22:22 ET CGI announces private offering of C$500 million, in aggregate, of 3.25 year and 4.75 year senior unsecured notes
titled Risk Environment of CGI's annual and quarterly MD&A, which is incorporated by reference in this cautionary statement. We also caution readers that the above-mentioned risks and the risks disclosed in CGI's annual and quarterly MD&A and other documents and filings are not the only ones
More news about: CGI Inc.
Sep 09, 2026, 22:17 ET Centrus Announces Pricing of $500 Million Underwritten Public Offering of Class A Common Stock and Warrants
BETHESDA, Md., Sept. 9, 2026 /PRNewswire/ -- Centrus Energy Corp. (NYSE: LEU) ("Centrus" or the "Company") today announced the pricing of its previously announced underwritten public offering of 500,000 shares of its Class
More news about: Centrus Energy Corp.
Sep 09, 2026, 20:30 ET Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World's First Phase III Trial of a Generative AI-Driven Innovative Drug
enabled this breakthrough with higher speed and reduced cost, which could make a lot of difference in the future of drug discovery," said Carol Satler, MD, PhD, Senior Vice President for Clinical Development, Non-Oncology at Insilico Medicine. "With the first patient dosed, we hope to see real-world
More news about: Insilico Medicine
Sep 09, 2026, 18:31 ET BetMGM Debuts Comprehensive Slate of Product and Pricing Enhancements for Football Season
(Available in the US), 877-8-HOPENY or text HOPENY (467369) (NY),1-800-327-5050 (MA),1-800-BETS-OFF (IA), 1-800-981-0023 (PR). Visit mdgamblinghelp.org (MD). 21+ only. New Customer Offer. Please Gamble Responsibly. See BetMGM.com for Terms. Subject to eligibility requirements. Bonus Bets are
More news about: BetMGM
Sep 09, 2026, 17:58 ET MedStar Health Offers New Nonsurgical Weight-Loss Procedure
Christopher You, MD , a board-certified general and bariatric surgeon at MedStar Franklin Square Medical Center, Aug. 21. The patient went home the same day.
More news about: MedStar Health
Sep 09, 2026, 17:06 ET Centrus Announces Proposed Public Underwritten Offering of Class A Common Stock and Warrants
BETHESDA, Md., Sept. 9, 2026 /PRNewswire/ -- Centrus Energy Corp. (NYSE: LEU) ("Centrus" or the "Company") today announced the launch of an underwritten public offering of shares of its Class A common stock (the "Class A Common
More news about: Centrus Energy Corp.
Sep 09, 2026, 16:01 ET AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for September 2026
BETHESDA, Md., Sept. 9, 2026 /PRNewswire/ -- AGNC Investment Corp. (Nasdaq: AGNC) announced today that its Board of Directors has declared a cash dividend of $0.12 per share of common stock for September 2026. The dividend
More news about: AGNC Investment Corp.
Sep 09, 2026, 16:01 ET AGNC Investment Corp. Declares Third Quarter Dividends on Preferred Stock
BETHESDA, Md., Sept. 9, 2026 /PRNewswire/ -- AGNC Investment Corp. (Nasdaq: AGNC) ("AGNC" or the "Company") announced today that its Board of Directors has declared cash dividends on the outstanding depositary shares1
More news about: AGNC Investment Corp.
Sep 09, 2026, 16:01 ET GEARWRENCH Continues to Expand Offering with Shop Cleaning Products
Three new products available now to combat common cleaning problems found in mechanic shopsHUNT VALLEY, Md., Sept. 9, 2026 /PRNewswire/ -- GEARWRENCH is expanding its shop solutions portfolio with products designed specifically
More news about: GEARWRENCH
Sep 09, 2026, 15:39 ET Marquis Who's Who Honors Monib A. Zirvi, MD, PhD, for Excellence in Dermatology
Marquis Who's Who announces the inclusion of Monib A. Zirvi, MD, PhD, in its biographical volumes in recognition of his more than two decades of contributions to dermatology, medical research and patient care.
More news about: Marquis Who's Who
Sep 09, 2026, 15:00 ET Atif M. Hussein, M.D., named chief of Memorial Cancer Institute
download multimedia:https://www.prnewswire.com/news-releases/atif-m-hussein-md-named-chief-of-memorial-cancer-institute-302874220.htmlSOURCE
More news about: Memorial Cancer Institute
Sep 09, 2026, 14:19 ET Anatool Launches to Improve Recognition and Treatment of Anaphylaxis
The tool was developed by FARE (Food Allergy Research & Education) in collaboration with Tim Dribin, MD, Division of Emergency Medicine at Cincinnati Children's. It is intended for professional use, not for the general public.The tool is based on
More news about: Cincinnati Children's Hospital Medical Center
Sep 09, 2026, 13:02 ET Atman Health Wins ARPA-H Award to Build Agentic AI for Cardiovascular Care, Starting with Heart Failure
workforce does not exist.Rahul Deo, MD, PhD, co-founder, CMO and CPO"In heart failure, a single wrong adjustment can put a patient in the emergency department with elevated potassium, kidney injury or an arrhythmia," said Rahul Deo, MD, PhD, co-founder, chief product officer and chief
More news about: Atman Health, Inc.
Sep 09, 2026, 13:00 ET ARPA-H Selects UpDoc to Lead Development of Autonomous Clinical AI System, in an Initiative Joined by Microsoft, OpenAI and NVIDIA
real-world deployment."ADVOCATE represents an unprecedented level of coordination across the federal health enterprise," said Haider Warraich, MD, Program Manager, ARPA-H. "ARPA-H is working alongside the FDA and the Office of the National Coordinator for Health IT (ONC), together with health systems,
More news about: UpDoc
Sep 09, 2026, 12:38 ET /C O R R E C T I O N -- Altesa Biosciences Inc./
"Inflammatory biomarkers are reduced by vapendavir treatment in rhinovirus-challenged COPD patients," was presented by Dr. Sebastian Johnston, MD, PhD, FMedSci, Professor of Respiratory Medicine and Allergy at the National Heart and Lung Institute, Imperial College London, in a session titled: "Respiratory
More news about: Altesa Biosciences Inc.
Sep 09, 2026, 12:36 ET Kaiser Permanente presents a fireside chat -- 'Tough pill to swallow: Balancing access and affordability in pharmacy'
director, Center for the Evaluation of Value and Risk in Health, Tufts Medical CenterMaisha Draves, MD, MPH, associate executive director, The Permanente Medical GroupStephen Parodi, MD, executive vice president, The Permanente Federation (moderator)When: Tuesday,
More news about: The Permanente Federation
Sep 09, 2026, 11:27 ET DCD Heart Transplant Outcomes Remain Stable During Rapid U.S. Expansion
outcomes.The findings open JCF's September special focus issue on heart transplantation, guest edited by Ersilia M. DeFilippis, MD; Randall C. Starling, MD, MPH; and Kiran Khush, MD, MAS. The issue examines a field undergoing significant change after decades in which immunosuppressive strategies and surgical
More news about: Heart Failure Society of America